People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cell Therapeutics Inc | — | Pharmaceuticals | Series A | $5.9M | $125.7M | 2010 |
Daniel G. Eramian at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel G. Eramian on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Frederick W. Telling | 1 | 3 |
| Craig W. Philips | 1 | 2 |
| John H Bauer | 1 | 2 |
| Richard L. Love | 1 | 1 |
| Jack W. Singer | 1 | 1 |
| Mary O. Mundinger | 1 | 1 |
| Phillip M. Nudelman | 1 | 1 |
| Vartan H. Gregorian | 1 | 1 |
| Louis A. Bianco | 1 | 1 |
| James A. Bianco | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.